3D-QSAR and Docking Studies of 4-morpholinopyrrolopyrimidine Derivatives as Potent mTOR Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|8|4|339-354

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.4, 2011-05, pp. : 339-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR and Molecular Docking Studies of Flavonoid Derivatives as Potent Acetylcholinesterase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 10, 2015-12 ,pp. : 837-7

Bentham Science Publishers

Access to resources Recommend Favorite

Combined 3D-QSAR, Pharmacophore and Docking Studies on Benzenesulfonamide Derivatives as Potent 12-Lipoxygenase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 74-82

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 3, 2014-12 ,pp. : 219-233

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR, Molecular Docking and Molecular Dynamics Studies of 2,4- Diarylaminopyrimidine Analogues (DAAP Analogues) as Potent ALK Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 270-286

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Binding Affinities for Hydroxamic Acid Derivatives as Urease Inhibitors by Molecular Docking and 3D-QSAR Studies

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 2, 2009-03 ,pp. : 93-100

Bentham Science Publishers

Access to resources Recommend Favorite